Date of Initial Handover meeting: 8 September 2022
Date of Final Handover meeting: 13 September 2022
Attendees
- Andrew Atkinson (AAT)
- Maria Braithwaite (MBR)
- Donna Morgan (DMO)
- Joe Schofield(JSC)
- Terance Shird (TSH)
- Rick Wood (RWO)
Page properties | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Agenda
Items to be discussed | Actions | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Prerelease Content Management Activities:
|
RESOLVED - ***** LATERALIZABLE REFSET AUTOMATION IS NO LONGER WORKING - Maria is asking Darryn to run it manually for now, until the problem can be permanently resolved in | ||||||||||||||||
2 | Discussion of existing Known Issues from the previous Release |
| ||||||||||||||||
3 | Content Validation
|
https://jira.ihtsdotools.org/browse/ATF-1673 https://jira.ihtsdotools.org/browse/INFRA-9473 3. Association Records not transferring through to the RF2 files as expectedhttps://jira.ihtsdotools.org/browse/ISRS-1271 AAT to validate all correct in the final AUGUST 2022 release... 4. Ref set description changes September 2022 release - MBR no changes identified via descriptions file. | ||||||||||||||||
4 | Mapping schedule | April 2022:
June 2022:
July 2022:
August 2022:
| ||||||||||||||||
5 | Brief run through of the known issues already identified by the content team during the QA batch process, to ensure that technical team are aware of them, and can either resolve them in time for the release, or confirm as known issues. | |||||||||||||||||
6 | DevOps resource confirmed | Terance will be the resource for the August release... | ||||||||||||||||
7 | Versioning and Change Freeze | Plan is to follow the new processes as now defined: AAT walked through and agreed new process with DevOps already, so unless there are any further questions/issues?? AAT to sign off PreProduction (unversioned) build before 09:00 on 17th August, and then:
| ||||||||||||||||
8 | Stats Report | Reports run via the reporting platform:
| ||||||||||||||||
9 | Risks |
| ||||||||||||||||
10 | AOB |